Antiverse
Designing antibodies for the most challenging targets
Cardiff, United States · Founded 2020 · $13.9M raised
- Headquarters
- Cardiff
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- antiverse.io
- Total Funding
- $13.9M
- Last Round
- $9.3M Series AMar 2026
- Rounds
- 2
About
Antiverse is a Cardiff, Wales-based techbio company that uses generative AI and advanced cell line engineering to design therapeutic antibodies against challenging drug targets, including G-protein coupled receptors and ion channels.
Summary
Antiverse is a Biotech company based in Cardiff, United States, founded in 2020. It has raised $13.9M in total across 2 rounds, most recently a $9.3M Series A round in Mar 2026. Investors include i&i Biotech Fund I and Kadmos Capital.
Tech & App Stack
1 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Mar 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...